2487 — Cutia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Cutia Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,378	1,077	1,273	876	788
Net Total Accounts Receivable
Net Total Receivables	0.499	4.12	77	105	183
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,402	1,145	1,416	1,087	1,043
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62.9	240	231	228	205
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,495	1,447	1,707	1,393	1,306
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.3	77.4	255	323	270
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,285	2,693	358	419	421
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-791	-1,246	1,349	975	885
Total Liabilities & Shareholders' Equity	1,495	1,447	1,707	1,393	1,306
Total Common Shares Outstanding